Cancer stem cell-targeted and drug resistant cancer therapy

The invention discloses a cancer stem cell-targeted and drug resistant cancer therapy. The present invention provides methods for preventing, treating, and/or managing cancer, the method comprising administering to a subject in need thereof therapeutically effective amount of sodium meta arsenite th...

Full description

Saved in:
Bibliographic Details
Main Author BURGER ANGELIKA
Format Patent
LanguageChinese
English
Published 01.12.2017
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention discloses a cancer stem cell-targeted and drug resistant cancer therapy. The present invention provides methods for preventing, treating, and/or managing cancer, the method comprising administering to a subject in need thereof therapeutically effective amount of sodium meta arsenite that reduces or eliminates drug resistant cancer stem cell populations as well as drug resistant mature cancer cells. 本发明公开了靶向癌症干细胞的耐药性癌症疗法。本发明特别提供了用于预防、治疗和/或管理癌症的方法，所述方法包含向需要的对象给药治疗有效量的、减少或消除耐药性癌症干细胞群以及耐药性成熟癌细胞的偏亚砷酸钠。
Bibliography:Application Number: CN201610829065